The competition between U.S. and Chinese biotech companies is particularly fierce in one field: CRISPR gene editing. Here are ...

The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the ...

In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies ...

China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina , just minutes ...

An ambitious project now aims to decipher the functions of all genes. Led by the National Institutes of Health, the MorPhiC Consortium is creating the first catalog of every gene function. Using ...

Illumina lowered its adjusted profit outlook and cut spending cost for 2025 as the company grapples with Chinese ban on its ...

China issued guidelines on Friday to promote biotech cultivation, focusing on gene-editing tools and developing new wheat, corn, and soybean varieties, as part of efforts to ensure food security ...

The stock is down 36% over the last year. China's Ministry of Commerce on Tuesday also said it will prohibit Illumina from exporting gene sequences to China after being placed on the "unreliable ...